(Q40800167)

English

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

0 references

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

0 references

multiple sclerosis

0 references

0 references

1 reference

based on heuristic

inferred from title

Charles R Guttmann

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Claudio Gasperini

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Massimo Filippi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

author name string

L Kappos

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

D Moeri

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

E W Radue

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

A Schoetzau

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

K Schweikert

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

F Barkhof

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

D Miller

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

H L Weiner

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

language of work or name

0 references

publication date

1 March 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

353

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

9157

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

964-969

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of magnetic resonance techniques in understanding and managing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An attempt to quantify magnetic resonance imaging in multiple sclerosis--correlation with clinical parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple sclerosis: gadolinium enhancement in MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

MRI dynamics of brain and spinal cord in progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The natural history of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of the placebo-treated groups in clinical trials of progressive MS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical scoring methods for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903053-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(98)03053-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10459905%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40800167&oldid=1507280472"